Wcn23-1085 a phase 3, randomized, double-blind, placebo-controlled study of atrasentan in patients with iga nephropaty- the align study

H. Lambers Heerspink, M. Jardine, D.E. Kohan,R. Lafayette,A. Levin, A. Liew,H. Zhang, K. Sheth,M. Camargo, C. Jones-Burton,A.J. King,J. Barratt

Kidney International Reports(2023)

引用 0|浏览5
暂无评分
关键词
atrasentan,double-blind,placebo-controlled
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要